Search results

Selected filters:

Brand management

Article type

Topic

Sector

Regions

3,089 results found for your search

Sort options
03 October 2019

Trump’s Nickelback copyright takedown is a reminder that legal teams must prepare for 2020 election

US President Donald Trump had a video removed from Twitter following a report of copyright infringement. We look at why brand misuse could increase significantly during the 2020 US presidential election.

02 October 2019

“A frankly pointless step” – why Banksy pop-up shop could hinder trademark case

Anonymous street artist Banksy has opened a pop-up shop in London in response to an ongoing trademark dispute with a card manufacturer. The attorney representing the card company reacts to the opening.

02 October 2019

Countering copycat restaurants and resisting cease-and-desist marketing stunts: exclusive interview with TGI Fridays

TGI Fridays trademark lead Leanne Stendell explains how she built an in-house trademark team from the ground up to meet the needs of a restaurant chain with over 50 years of goodwill.

02 October 2019

US trademark litigation levels continue upward trend; 2019 on course for four-year high

New data reveals that 3,441 trademark litigation actions have been filed in the United States to date. The figures mean that 2019 is on course to represent a four-year high in filings.

01 October 2019

Apple MEMOJI lawsuit, Malaysia joins Madrid System, and TMview adds OAPI: news digest

In our latest round-up, we look at Huawei filing a lawsuit against a rival Chinese mobile maker, POW! Entertainment hitting back over Stan Lee lawsuit, Alt Legal acquiring MarkTend, and much more.

01 October 2019

Procedures and strategies for pharmaceutical brands: Russia

In 2018 the top development strategy of companies involved in the Russian pharmaceutical market was ‘aggressive marketing’. In such circumstances, trademark registration takes on considerable importance as it provides an effective measure to secure exclusive rights over a product’s unique identity. 

01 October 2019

Procedures and strategies for pharmaceutical brands: Turkey

Several pharmaceutical trademarks exist that have not yet been put to use, mostly as a result of licensing problems, and are therefore vulnerable to non-use defence. Any opposition on the basis of such kinds of trademark can be overcome by non-use defence.

01 October 2019

Turning the tide: how China is fighting back against malicious filings

Amendments to China’s Trademark Law are due to take effect on 1 November 2019. The changes should aid the authorities in their bid to crack down on malicious filings and trademark hoarding.

01 October 2019

Procedures and strategies for pharmaceutical brands: United States

Recent developments in US federal law now permit the sale of cannabis-derived products under certain conditions in states where such products are also legal under state law. This will have implications for the selection and protection of pharmaceutical trademarks.

01 October 2019

Procedures and strategies for pharmaceutical brands: Mexico

There is no clear link between the IP Law and the Health Law and their regulations regarding conflicts between registered trademarks and marketing authorisations or distinctive names.

01 October 2019

Procedures and strategies for pharmaceutical brands: Romania

In Romania, pharmaceutical trademarks are governed by the same national legislation and relevant EU directives and regulations as other trademarks. However, some specific elements must be taken into account.

01 October 2019

Procedures and strategies for pharmaceutical brands: Saudi Arabia

There are no specific provisions relating to international non-proprietary names (INNs) in Saudi Arabia’s Trademark Law. As a member of the WHO, in practice Saudi Arabia implements the World Health Assembly resolution over INNs.

01 October 2019

Procedures and strategies for pharmaceutical brands: United Kingdom

Given the highly profitable trade in pharmaceutical parallel imports where price differences and arbitrage opportunities arise from different national pricing regulations, it is anticipated that the issue of parallel imports will remain a significant area of concern for pharmaceutical companies.

01 October 2019

Asia’s top filers reveal strong growth prospects

World Trademark Review takes a deep dive into the top Asia-Pacific trademark offices and how they are modernising their systems to better protect applicants and streamline procedures. While this has positively affected filing levels, economic performance and domestic businesses will be key going forward.

01 October 2019

Colour marks: still a grey area?

Colour marks remain difficult to obtain, but brand owners can take certain steps to enhance their chances of success.